Table 5.
Viability assays of strains of Candida spp. e × posed to sub-inhibitory concentrations of oils of C. copticum , T. vulgaris and thymol
| Test agents (sub-MICs) | Cell viability assay (log cfu.mL−1at 105dilution) | |||||||
|---|---|---|---|---|---|---|---|---|
| C. albicans04 | C. albicans05 | C. albicans07 | C. albicans09 | C. albicans16 | C. albicansMTCC183 | C. albicansSC5314 | C. tropicalis01 | |
| Untreated | 8.14 ± 0.02 | 8.04 ± 0.01 | 8.12 ± 0.03 | 8.25 ± 0.01 | 8.02 ± 0.04 | 8.19 ± 0.01 | 8.45 ± 0.03 | 8.07 ± 0.04 |
| Essential oils | ||||||||
| C. copticum | ||||||||
| 0.25 × MIC | 7.16 ± 0.04 | 7.29 ± 0.07 | 7.34 ± 0.03 | 7.26 ± 0.04 | 7.40 ± 0.06 | 7.38 ± 0.05 | 7.60 ± 0.02 | 7.41 ± 0.04 |
| 0.5 × MIC | 6.10 ± 0.03 | 6.39 ± 0.05 | 6.46 ± 0.04 | 6.24 ± 0.02 | 6.35 ± 0.03 | 6.44 ± 0.04 | 7.17 ± 0.01 | 6.98 ± 0.05 |
| T. vulgaris | ||||||||
| 0.25 × MIC | 7.09 ± 0.03 | 7.24 ± 0.06 | 7.14 ± 0.05 | 7.19 ± 0.05 | 7.37 ± 0.04 | 7.32 ± 0.05 | 7.71 ± 0.04 | 7.52 ± 0.02 |
| 0.5 × MIC | 6.43 ± 0.06 | 6.41 ± 0.05 | 6.39 ± 0.07 | 6.19 ± 0.04 | 6.27 ± 0.06 | 6.44 ± 0.07 | 7.02 ± 0.04 | 6.71 ± 0.06 |
| Thymol | ||||||||
| 0.25 × MIC | 7.11 ± 0.02 | 7.16 ± 0.04 | 7.23 ± 0.06 | 7.22 ± 0.03 | 7.24 ± 0.06 | 7.26 ± 0.05 | 7.44 ± 0.07 | 7.29 ± 0.03 |
| 0.5 × MIC | 6.23 ± 0.04 | 6.54 ± 0.03 | 6.44 ± 0.03 | 6.33 ± 0.06 | 6.23 ± 0.05 | 6.33 ± 0.05 | 7.08 ± 0.07 | 6.45 ± 0.05 |
| Antifungal drug | ||||||||
| Fluconazole | ||||||||
| 0.25 × MIC | 7.08 ± 0.03 | 7.11 ± 0.06 | 7.23 ± 0.05 | 7.16 ± 0.05 | 7.22 ± 0.04 | 7.31 ± 0.04 | 7.14 ± 0.06 | 7.31 ± 0.05 |
| 0.5 × MIC | 6.18 ± 0.04 | 6.45 ± 0.06 | 6.44 ± 0.05 | 6.27 ± 0.04 | 6.15 ± 0.06 | 6.04 ± 0.05 | 7.23 ± 0.04 | 6.88 ± 0.06 |
Within the columns, untreated means followed by treated means are non-significantly different according to Duncan’s multiple range tests (P < 0.05).